文献速递肝病消化道肿瘤与早癌

黄曲霉毒素相关肝细胞癌的遗传特征

Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
PubMed 文献 · Gastroenterology · 2017-03-29

研究对比了49例来自中国黄曲霉毒素高暴露区的黄曲霉毒素相关肝细胞癌与1072例其他地区肝细胞癌的基因组特征。发现黄曲霉毒素相关肝癌常见C>A颠换、GCN序列基序和链偏倚,除TP53外还有ADGRB1频繁突变,后者与肿瘤毛细血管密度增加相关,且肿瘤组织含高水平潜在突变相关新抗原、大量浸润淋巴细胞和表达PD-L1的肿瘤细胞。中国肝癌中9.8%具有黄曲霉毒素相关遗传特征,其他地区为0.4%-3.5%。

要点

  • 黄曲霉毒素相关肝细胞癌常见C>A颠换、GCN序列基序和链偏倚。
  • 除TP53外,ADGRB1基因频繁突变,与肿瘤组织毛细血管密度增加相关。
  • 中国肝癌中9.8%具有黄曲霉毒素相关遗传特征,其他地区为0.4%-3.5%。

核心结论

  • 研究识别出黄曲霉毒素相关肝细胞癌的特异性遗传和突变特征,包括ADGRB1突变,与一般人群肝细胞癌不同。
  • 这些突变与肿瘤组织血管化增加和PD-L1表达相关。
  • 这些发现可能用于识别因黄曲霉毒素暴露导致的肝细胞癌患者,并选择治疗。

研究设计与样本

  • 研究获取中国启东肝癌医院研究所1990年至2016年间49例患者的肝细胞癌肿瘤组织和匹配的非肿瘤肝组织,该地区为黄曲霉毒素暴露高风险区,38.2%的食品样本黄曲霉毒素污染检测阳性。
  • 使用GATK最佳实践流程识别体细胞变异,部分全基因组测序和全外显子组测序突变通过Sanger测序验证。
  • 分析来自中国、美国、法国和日本的5个数据集共1072例肝细胞癌基因组,使用Wellcome Trust Sanger研究所突变特征框架和非负矩阵分解分析49例黄曲霉毒素相关肝细胞癌和1072例其他地区肝细胞癌的突变。
  • 比较黄曲霉毒素相关肝细胞癌与一般人群肝细胞癌的突变图谱和突变特征,识别黄曲霉毒素相关肝细胞癌的遗传特征并用于在其他地区数据集中识别黄曲霉毒素相关肝细胞癌。
  • 肿瘤样本通过免疫组织化学分析微血管密度及CD34和CD274(PD-L1)水平。

主要发现

  • 黄曲霉毒素相关肝细胞癌常见C>A颠换、序列基序GCN和链偏倚。
  • 除先前报道的TP53突变外,发现粘连G蛋白偶联受体B1基因(ADGRB1)频繁突变,与肿瘤组织毛细血管密度增加相关。
  • 与无黄曲霉毒素暴露的肝细胞癌相比,黄曲霉毒素相关肝细胞癌组织含高水平潜在突变相关新抗原、大量浸润淋巴细胞和表达PD-L1的肿瘤细胞。
  • 中国肝细胞癌中9.8%含黄曲霉毒素相关遗传特征,其他地区肝细胞癌中0.4%-3.5%含这些遗传特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Dietary exposure to aflatoxin is an important risk factor for hepatocellular carcinoma (HCC). However, little is known about the genomic features and mutations of aflatoxin-associated HCCs compared with HCCs not associated with aflatoxin exposure. We investigated the genetic features of aflatoxin-associated HCC that can be used to differentiate them from HCCs not associated with this carcinogen. METHODS: We obtained HCC tumor tissues and matched non-tumor liver tissues from 49 patients, collected from 1990 through 2016, at the Qidong Liver Cancer Hospital Institute in China-a high-risk region for aflatoxin exposure (38.2% of food samples test positive for aflatoxin contamination). Somatic variants were identified using GATK Best Practices Pipeline. We validated part of the mutations from whole-genome sequencing and whole-exome sequencing by Sanger sequencing. We also analyzed genomes of 1072 HCCs, obtained from 5 datasets from China, the United States, France, and Japan. Mutations in 49 aflatoxin-associated HCCs and 1072 HCCs from other regions were analyzed using the Wellcome Trust Sanger Institute mutational signatures framework with non-negative matrix factorization. The mutation landscape and mutational signatures from the aflatoxin-associated HCC and HCC samples from general population were compared. We identified genetic features of aflatoxin-associated HCC, and used these to identify aflatoxin-associated HCCs in datasets from other regions. Tumor samples were analyzed by immunohistochemistry to determine microvessel density and levels of CD34 and CD274 (PD-L1). RESULTS: Aflatoxin-associated HCCs frequently contained C>A transversions, the sequence motif GCN, and strand bias. In addition to previously reported mutations in TP53, we found frequent mutations in the adhesion G protein-coupled receptor B1 gene (ADGRB1), which were associated with increased capillary density of tumor tissue. Aflatoxin-associated HCC tissues contained high-level potential mutation-associated neoantigens, and many infiltrating lymphocytes and tumors cells that expressed PD-L1, compared to HCCs not associated with aflatoxin. Of the HCCs from China, 9.8% contained the aflatoxin-associated genetic features, whereas 0.4%-3.5% of HCCs from other regions contained these genetic features. CONCLUSIONS: We identified specific genetic and mutation features of HCCs associated with aflatoxin exposure, including mutations in ADGRB1, compared to HCCs from general populations. We associated these mutations with increased vascularization and expression of PD-L1 in HCC tissues. These findings might be used to identify patients with HCC due to aflatoxin exposure, and select therapies.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Zhang W, He H, Zang M, et al. Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma. Gastroenterology. 2017. PMID: 28363643. doi:10.1053/j.gastro.2017.03.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。